Home › NDC Lookup › RxCUI directory › RxCUI 883358

Calcitriol 0.000003 MG/MG Topical Ointment [Vectical] — RxCUI 883358

RxNorm drug concept · Semantic branded drug
RxCUI 883358 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI883358
Official nameCalcitriol 0.000003 MG/MG Topical Ointment [Vectical]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asVectical 0.0003 % Topical Ointment; Vectical 0.000003 MG/MG Topical Ointment; Vectical 3 MCG/GM Topical Ointment
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Calcitriol Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats mild to moderate plaque psoriasis, the raised scaly skin patches. Vectical Ointment is approved for adults and children 2 years and older.
  • Apply it to the affected skin twice a day, morning and evening. Keep it off your eyes, lips and face, and never swallow it. Stay within the weekly maximum your prescriber gives you...
  • The most common are skin discomfort and itching. Some people have higher calcium in blood or urine, which shows up on lab tests. Burning or redness can also happen.
  • Call if you get blistering skin or signs of high calcium. If your calcium tests are abnormal, treatment should be paused until they return to normal.
📖 Read our full Calcitriol Topical guide →

🕸️ Concept Web — How Calcitriol 0.000003 MG/MG Topical Ointment [Vect... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Calcitriol 0.000003 MG/MG Topical Ointment [Vectical] RxCUI 883358

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Calcitriol 1894
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Vectical 831894
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Calcitriol Topical Ointment 393343
    • Calcitriol Topical Product 1153001
    • Calcitriol Topical Ointment [Vectical] 831896
    • Vectical Topical Product 1187749
    • Topical Ointment 316985
    • Topical Product 1151122
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Calcitriol 0.000003 MG/MG [Vectical] SBDC · 883357
  • Calcitriol Topical Ointment [Vectical] SBDF · 831896
  • Vectical Topical Product SBDG · 1187749
  • Vectical BN · 831894

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 883358 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00299-2012-05 5 g in 1 TUBE (0299-2012-05) Vectical Galderma Laboratories, L.P. 2009-02-01
00299-2012-10 1 TUBE in 1 CARTON (0299-2012-10) / 100 g in 1 TUBE Vectical Galderma Laboratories, L.P. 2009-02-01
Observed labelers: Galderma Laboratories, L.P. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.